PMC:7253235 / 33554-34905
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1176 | 96-100 | Gene | denotes | CCR5 | Gene:1234 |
1177 | 163-167 | Gene | denotes | CCR5 | Gene:1234 |
1178 | 662-666 | Gene | denotes | CCR5 | Gene:1234 |
1179 | 725-729 | Gene | denotes | CCR5 | Gene:1234 |
1180 | 1062-1066 | Gene | denotes | IL-6 | Gene:3569 |
1181 | 1083-1086 | Gene | denotes | CD4 | Gene:920 |
1182 | 1087-1090 | Gene | denotes | CD8 | Gene:925 |
1183 | 955-963 | Species | denotes | patients | Tax:9606 |
1184 | 1248-1256 | Species | denotes | patients | Tax:9606 |
1185 | 1313-1321 | Species | denotes | patients | Tax:9606 |
1186 | 116-131 | Gene | denotes | tyrosine kinase | Gene:7294 |
1187 | 522-531 | Chemical | denotes | maraviroc | MESH:D000077592 |
1188 | 536-546 | Chemical | denotes | vicriviroc | MESH:C486781 |
1189 | 587-597 | Chemical | denotes | leronlimab | MESH:C420063 |
1190 | 20-26 | Disease | denotes | cancer | MESH:D009369 |
1191 | 78-86 | Disease | denotes | COVID-19 | MESH:C000657245 |
1192 | 614-630 | Disease | denotes | multiple cancers | MESH:D009369 |
1193 | 694-700 | Disease | denotes | cancer | MESH:D009369 |
1194 | 782-811 | Disease | denotes | colorectal and breast cancers | MESH:D001943 |
1195 | 946-954 | Disease | denotes | COVID-19 | MESH:C000657245 |
1196 | 1124-1132 | Disease | denotes | COVID-19 | MESH:C000657245 |
1197 | 1133-1140 | Disease | denotes | viremia | MESH:D014766 |
1198 | 1266-1280 | Disease | denotes | critically ill | MESH:D016638 |
1199 | 1334-1340 | Disease | denotes | cancer | MESH:D009369 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T83 | 116-124 | Body_part | denotes | tyrosine | http://purl.org/sig/ont/fma/fma82768 |
T84 | 182-191 | Body_part | denotes | G protein | http://purl.org/sig/ont/fma/fma61788 |
T85 | 234-245 | Body_part | denotes | macrophages | http://purl.org/sig/ont/fma/fma63261 |
T86 | 249-254 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T87 | 256-267 | Body_part | denotes | eosinophils | http://purl.org/sig/ont/fma/fma62861 |
T88 | 269-284 | Body_part | denotes | dendritic cells | http://purl.org/sig/ont/fma/fma273565 |
T89 | 279-284 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
T90 | 290-299 | Body_part | denotes | microglia | http://purl.org/sig/ont/fma/fma68923 |
T91 | 321-330 | Body_part | denotes | chemokine | http://purl.org/sig/ont/fma/fma241981 |
T92 | 405-408 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
T93 | 563-571 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
T94 | 797-803 | Body_part | denotes | breast | http://purl.org/sig/ont/fma/fma9601 |
T95 | 833-846 | Body_part | denotes | immune system | http://purl.org/sig/ont/fma/fma9825 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T44 | 797-803 | Body_part | denotes | breast | http://purl.obolibrary.org/obo/UBERON_0000310 |
T45 | 833-846 | Body_part | denotes | immune system | http://purl.obolibrary.org/obo/UBERON_0002405 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T346 | 20-26 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
T347 | 78-86 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T348 | 797-811 | Disease | denotes | breast cancers | http://purl.obolibrary.org/obo/MONDO_0007254 |
T349 | 946-954 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T350 | 1124-1132 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T351 | 1334-1340 | Disease | denotes | cancer | http://purl.obolibrary.org/obo/MONDO_0004992 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T260 | 180-181 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T261 | 182-208 | http://purl.obolibrary.org/obo/PR_000030035 | denotes | G protein–coupled receptor |
T262 | 247-254 | http://purl.obolibrary.org/obo/CL_0000084 | denotes | T cells |
T263 | 269-284 | http://purl.obolibrary.org/obo/CL_0000451 | denotes | dendritic cells |
T264 | 290-299 | http://purl.obolibrary.org/obo/CL_0000129 | denotes | microglia |
T265 | 340-349 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signaling |
T266 | 351-353 | http://purl.obolibrary.org/obo/CLO_0001527 | denotes | 94 |
T267 | 370-373 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T268 | 673-676 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T269 | 692-693 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T270 | 797-803 | http://purl.obolibrary.org/obo/UBERON_0000310 | denotes | breast |
T271 | 817-819 | http://purl.obolibrary.org/obo/CLO_0001527 | denotes | 94 |
T272 | 833-846 | http://purl.obolibrary.org/obo/UBERON_0002405 | denotes | immune system |
T273 | 1083-1086 | http://purl.obolibrary.org/obo/PR_000001004 | denotes | CD4 |
T274 | 1087-1090 | http://purl.obolibrary.org/obo/CLO_0053438 | denotes | CD8 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T95 | 116-142 | Chemical | denotes | tyrosine kinase inhibitors | http://purl.obolibrary.org/obo/CHEBI_38637 |
T96 | 116-124 | Chemical | denotes | tyrosine | http://purl.obolibrary.org/obo/CHEBI_18186 |
T97 | 132-142 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T98 | 184-191 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T99 | 409-418 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
T100 | 497-505 | Chemical | denotes | molecule | http://purl.obolibrary.org/obo/CHEBI_25367 |
T101 | 522-531 | Chemical | denotes | maraviroc | http://purl.obolibrary.org/obo/CHEBI_63608 |
T102 | 1062-1064 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T16 | 62-74 | http://purl.obolibrary.org/obo/GO_0009405 | denotes | pathogenesis |
T17 | 125-142 | http://purl.obolibrary.org/obo/GO_0033673 | denotes | kinase inhibitors |
T18 | 340-349 | http://purl.obolibrary.org/obo/GO_0023052 | denotes | signaling |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T182 | 20-26 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |
T183 | 797-811 | Phenotype | denotes | breast cancers | http://purl.obolibrary.org/obo/HP_0003002 |
T184 | 1133-1140 | Phenotype | denotes | viremia | http://purl.obolibrary.org/obo/HP_0020071 |
T185 | 1334-1340 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T213 | 0-158 | Sentence | denotes | There are potential cancer treatments that may counteract the pathogenesis of COVID-19, such as CCR5 treatments and tyrosine kinase inhibitors (TKIs) [91–93]. |
T214 | 159-355 | Sentence | denotes | The CCR5 receptor is a G protein–coupled receptor selectively expressed on macrophages, T cells, eosinophils, dendritic cells, and microglia and is implicated in chemokine-mediated signaling [94]. |
T215 | 356-603 | Sentence | denotes | This receptor has historically been targeted for HIV antiviral therapy, in the setting of disrupting viral entry, specifically through small molecule inhibition with maraviroc and vicriviroc, and monoclonal antibody treatment with leronlimab [95]. |
T216 | 604-724 | Sentence | denotes | Moreover, multiple cancers have been shown to overexpress CCR5 which has been linked to a cancer’s metastatic potential. |
T217 | 725-821 | Sentence | denotes | CCR5 therapies are currently being studied in metastatic colorectal and breast cancers [91, 94]. |
T218 | 822-973 | Sentence | denotes | Due to its immune system restorative properties, leronlimab is being investigated for compassionate use in the treatment of COVID-19 patients [96, 97]. |
T219 | 974-1146 | Sentence | denotes | Studies examining receptor blockade in leronlimab preliminarily have shown decreases in IL-6, restoration of CD4/CD8 ratios, and reduction in overall COVID-19 viremia [98]. |
T220 | 1147-1351 | Sentence | denotes | These collective findings suggest possible therapeutic role in establishing immune reconstitution in patients that are critically ill and may provide dual benefit in patients with shared cancer diagnoses. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32462289-31292161-24380986 | 151-153 | 31292161 | denotes | 91 |
32462289-32032529-24380986 | 151-153 | 32032529 | denotes | 91 |
32462289-32113509-24380986 | 151-153 | 32113509 | denotes | 91 |
32462289-22637726-24380987 | 351-353 | 22637726 | denotes | 94 |
32462289-16905787-24380988 | 599-601 | 16905787 | denotes | 95 |
32462289-31292161-24380989 | 813-815 | 31292161 | denotes | 91 |
32462289-22637726-24380990 | 817-819 | 22637726 | denotes | 94 |